Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2020-12-03 2020-12-03
Drug Identification Number 02242539 02242539
Brand name TEVA-DILTIAZEM CD TEVA-DILTIAZEM CD
Common or Proper name DILTIAZEM CD 180MG CAPS DILTIAZEM CD 180MG CAPS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients DILTIAZEM HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE
Strength(s) 180MG 180MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code C08DB C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-12-02 2020-12-02
Estimated end date 2020-12-31 2020-12-31
Actual end date 2020-12-02 2020-12-02
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Reported in error Reported in error
Health Canada comments